IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $49,000 | – | 10,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,236,394 | $5,626,000 | 8.66% |
| Versant Venture Management, LLC | 2,208,210 | $10,047,356,000 | 3.14% |
| EcoR1 Capital, LLC | 4,437,600 | $20,191,000 | 1.92% |
| BVF INC/IL | 4,158,353 | $18,921,000 | 1.85% |
| Abingworth LLP | 352,300 | $1,621,000 | 0.93% |
| DAFNA Capital Management LLC | 328,500 | $1,495,000 | 0.70% |
| Bain Capital Public Equity Management, LLC | 1,221,368 | $5,557,000 | 0.38% |
| Portolan Capital Management | 444,875 | $2,024,000 | 0.21% |
| Telemetry Investments, L.L.C. | 113,500 | $516,000 | 0.20% |
| C M BIDWELL & ASSOCIATES LTD | 13,055 | $59,000 | 0.06% |